Pancreatic Cancer Part 5 Figure 89-2 Survival by adjuvant chemotherapy.. Kaplan-Meier estimates of survival... from the European Study Group for Pancreatic Cancer 1 ESPAC1 trial for th
Trang 1Chapter 089 Pancreatic Cancer
(Part 5)
Figure 89-2
Survival by adjuvant chemotherapy Kaplan-Meier estimates of survival
Trang 2from the European Study Group for Pancreatic Cancer 1 (ESPAC1) trial for the comparison of adjuvant chemotherapy versus no adjuvant chemotherapy (CT) in patients with resected pancreatic cancer (hazard ratio for death, 0.71; 95%
confidence interval, 0.55 to 0.92; p = 009) (Reprinted with permission from JP
Neoptolemos, DD Stocken, H Friess, et al: A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer N Engl J Med 350:1200–1210, 2004 Copyright 2004, Massachusetts Medical Society.)
Further Readings
Alexakis N et al: Current standards of surgery for pancreatic cancer Br J Surg 91:1410, 2004 [PMID: 15499648]
Barugola G et al: The determinant factors of recurrence following resection for ductal pancreatic cancer JOP 8(Suppl 1):132, 2007
Chua YJ, Cunningham D: Chemotherapy for advanced pancreatic cancer
Trang 3Best Pract Res Clin Gastroenterol 20:327, 2006 [PMID: 16549331]
DiMagno EP et al: AGA technical review on the epidemiology, diagnosis, and treatment of pancreatic ductal adenocarcinomas American Gastroenterological Association Gastroenterology 117:1464, 1999 [PMID: 10579989]
Greene FL, Page DL (eds.): Exocrine Pancreas, AJCC Cancer Staging
Manual, 6th ed, New York, Springer, pp 157–164, 2002
Neoptolemos JP et al: A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer N Engl J Med 350:1200, 2004 [PMID: 15028824]
Willett CG et al: Locally advanced pancreatic cancer J Clin Oncol
Trang 423:4538, 2005 [PMID: 16002845]
Bibliography
Goggins M: Molecular markers of early pancreatic cancer J Clin Oncol 23:4524, 2005 [PMID: 16002843]